Technology | November 14, 2025
Terumo BCT and Santersus partner to advance blood purification therapy for sepsis
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
Revenues up 13.1% year-over-year; Continued momentum driven by organic growth, strategic partnerships, and acquisitions
New study presents a human-relevant stress model for assessing potential therapeutics
Investment to expand manufacturing and global medicine supply capacity
The study further confirmed that GAL-101 effectively crosses the blood-brain barrier
Nu Nutridac is a nutritional replenisher for neurodegenerative and anxiety-related disorders
Prof. Götz is Director of the Institute of Stem Cell Research at Helmholtz Center Munich and Chair of Physiological Genomics at Ludwig-Maximilians-Universität, Munich
Acquisition adds potential best-in-class disease-modifying therapy for Alzheimer's disease
Strengthening focus in Alzheimer's disease and neuroscience pipeline
The company plans to advance Ropanicant into double-blind, placebo-controlled Phase-2b clinical study in MDD patients, anticipated to start in early 2025
Subscribe To Our Newsletter & Stay Updated
